Rating quality of evidence and strength of recommendations

What is “quality of evidence” and why is it important to clinicians?

BMJ 2008; 336 doi: http://dx.doi.org/10.1136/bmj.39490.551019.BE (Published 1 May 2008)
Cite this as: BMJ 2008;336:995

Related articles

Research Methods & Reporting: Uncertainties in baseline risk estimates and confidence in treatment effects

Research: Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence

Research: Speed of updating online evidence based point of care summaries: prospective cohort analysis

Research: Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

Analysis: Norway’s new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds

Research: Use of weaning protocols for reducing duration of mechanical ventilation in critically ill adult patients: Cochrane systematic review and meta-analysis

Research: Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

Research: Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

Editorial: What should clinicians do when faced with conflicting recommendations?

Analysis: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

Analysis: Going from evidence to recommendations

Education and debate: Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Paper: Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational studyCommentary: Varied preferences reflect the reality of clinical practice

See more

Letter: Inactivity, not gluttony, causes obesity

Letter: Reporting unexpected benefit through the yellow card system

Letter: Wim van den Brink and colleagues reply to Des Spence and Alain Braillon

News: Drug company boards often include academic medical center officials, says US study

This article has been cited by other articles: